Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

For these recommendations to be put in place and for many more people with DR-TB to receive treatment, MSF today called on the US pharmaceutical corporation Johnson and Johnson (J&J), which produces bedaquiline, to take immediate steps to make the drug affordable for all who need it, in particular in low- and middle-income and high DR-TB burden countries.

South Africa breaks the ‘silence’ period and negotiations are re-opened

MSF calls out ViiV Healthcare—a division of US and UK pharmaceutical corporations Pfizer and GlaxoSmithKline plus Japan’s Shionogi—for preventing children with HIV from getting child-appropriate formulations of a critical HIV medicine, dolutegravir.

RCEP trade deal could cut medicines lifeline for people in developing countries